Allogene Therapeutics (ALLO)'s 30-day implied volatility (IV30) was 82.9% at the close on November 11, 2026, up from 72.3% the day before, against a 52-week range of 51.1% to 189.5%. Its 20-day historical volatility was 83.4%.
Data as of November 11, 2026.